HP518

HP518 · Hinova Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HP518, covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients [Phase 1, Phase 2]

See pricing